Literature DB >> 7640047

Detection of TP53 gene mutations in human sarcomas.

J S Castresana1, M P Rubio, L Gómez, A Kreicbergs, A Zetterberg, C Barrios.   

Abstract

To determine the frequency and type of TP53 mutations in human sarcomas, we examined exons 5-8 of the TP53 gene in 48 sarcomas using single-strand conformation polymorphism (SSCP) analysis and direct sequencing. Nine tumours had mobility-shifts on SSCP analysis, and sequencing of six of these tumours revealed 10 mutations: one insertion, two deletions and seven point mutations (four transitions and three transversions). Four of these mutations resulted in frame-shifts, one in a truncated protein, four cases in mono-allelic point mutations and one case in an altered splice site. These data show that approximately 20% of sarcomas harbour TP53 gene alterations and illustrate a variety of TP53 gene mutation types.

Entities:  

Mesh:

Year:  1995        PMID: 7640047     DOI: 10.1016/0959-8049(95)00121-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

Review 1.  Soft tissue sarcomas and p53 mutations.

Authors:  H Taubert; A Meye; P Würl
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

2.  Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma.

Authors:  Rex C Haydon; Andrea Deyrup; Akira Ishikawa; Robert Heck; Wei Jiang; Lan Zhou; Tao Feng; David King; Hongwei Cheng; Benjamin Breyer; Terrance Peabody; Michael A Simon; Anthony G Montag; Tong-Chuan He
Journal:  Int J Cancer       Date:  2002-12-01       Impact factor: 7.396

3.  Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics.

Authors:  Gaëlle Pérot; Frédéric Chibon; Audrey Montero; Pauline Lagarde; Hugues de Thé; Philippe Terrier; Louis Guillou; Dominique Ranchère; Jean-Michel Coindre; Alain Aurias
Journal:  Am J Pathol       Date:  2010-10       Impact factor: 4.307

Review 4.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

Review 5.  Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

Authors:  James J Morrow; Chand Khanna
Journal:  Crit Rev Oncog       Date:  2015

6.  DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies.

Authors:  Wolfgang M Schmidt; Mohammed H Uddin; Sandra Dysek; Karin Moser-Thier; Christine Pirker; Harald Höger; Inge M Ambros; Peter F Ambros; Walter Berger; Reginald E Bittner
Journal:  PLoS Genet       Date:  2011-04-14       Impact factor: 5.917

7.  Targeting the p53 Pathway in Ewing Sarcoma.

Authors:  Paul M Neilsen; Kathleen I Pishas; David F Callen; David M Thomas
Journal:  Sarcoma       Date:  2010-12-09

8.  Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma.

Authors:  Simona Ognjanovic; Ghyslaine Martel; Carlos Manivel; Magali Olivier; Erica Langer; Pierre Hainaut
Journal:  Sarcoma       Date:  2012-03-07

9.  Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours.

Authors:  G Nawa; Y Miyoshi; H Yoshikawa; T Ochi; Y Nakamura
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

10.  Frequent p53 gene mutations in soft tissue sarcomas arising in burn scar.

Authors:  H Nakanishi; Y Tomita; H Yoshikawa; N Sato; T Ochi; K Aozasa
Journal:  Jpn J Cancer Res       Date:  1999-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.